IYY

L-cystine

Created:2022-04-20
Last modified:  2022-08-31

Find related ligands:

Chemical Details

Formal Charge0
Atom Count26
Chiral Atom Count2
Bond Count25
Aromatic Bond Count0
2D diagram of IYY

WebGL does not seem to be available.

This can be caused by an outdated browser, graphics card driver issue, or bad weather. Sometimes, just restarting the browser helps. Also, make sure hardware acceleration is enabled in your browser.

For a list of supported browsers, refer to http://caniuse.com/#feat=webgl.

Chemical Component Summary

NameL-cystine
Synonyms(2R)-2-azanyl-3-[[(2R)-2-azanyl-3-oxidanyl-3-oxidanylidene-propyl]disulfanyl]propanoic acid
Systematic Name (OpenEye OEToolkits)(2~{R})-2-azanyl-3-[[(2~{R})-2-azanyl-3-oxidanyl-3-oxidanylidene-propyl]disulfanyl]propanoic acid
FormulaC6 H12 N2 O4 S2
Molecular Weight240.3
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESCACTVS3.385N[CH](CSSC[CH](N)C(O)=O)C(O)=O
SMILESOpenEye OEToolkits2.0.7C(C(C(=O)O)N)SSCC(C(=O)O)N
Canonical SMILESCACTVS3.385 N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O
Canonical SMILESOpenEye OEToolkits2.0.7 C([C@@H](C(=O)O)N)SSC[C@@H](C(=O)O)N
InChIInChI1.06 InChI=1S/C6H12N2O4S2/c7-3(5(9)10)1-13-14-2-4(8)6(11)12/h3-4H,1-2,7-8H2,(H,9,10)(H,11,12)/t3-,4-/m0/s1
InChIKeyInChI1.06 LEVWYRKDKASIDU-IMJSIDKUSA-N

Drug Info: DrugBank

DrugBank IDDB00138 
NameCystine
Groups
  • approved
  • nutraceutical
DescriptionA covalently linked dimeric nonessential amino acid formed by the oxidation of cysteine. Two molecules of cysteine are joined together by a disulfide bridge to form cystine.
Synonyms
  • (R,R)-3,3'-dithiobis(2-aminopropanoic acid)
  • Cystine
  • L-Dicysteine
  • L-alpha-Diamino-beta-dithiolactic acid
  • β,β'-dithiodialanine
Brand Names
  • Distilpure Msm
  • Amino-cerv
  • Medi Msm (methyl Sulfonyl Methane)
IndicationIt has been claimed that L-cysteine has anti-inflammatory properties, that it can protect against various toxins, and that it might be helpful in osteoarthritis and rheumatoid arthritis. More research will have to be done before L-cysteine can be indicated for any of these conditions. Research to date has mostly been in animal models.
Categories
  • Amino Acids
  • Amino Acids, Diamino
  • Amino Acids, Dicarboxylic
  • Amino Acids, Peptides, and Proteins
  • Amino Acids, Sulfur
CAS number56-89-3

Drug Targets

NameTarget SequencePharmacological ActionActions
Cystine/glutamate transporterMVRKPVVSTISKGGYLQGNVNGRLPSLGNKEPPGQEKVQLKRKVTLLRGV...unknown
CystinosinMIRNWLTIFILFPLKLVEKCESSVSLTVPPVVKLENGSSTNVSLTLRPPL...unknown
Monocarboxylate transporter 10MVLSQEEPDSARGTSEAQPLGPAPTGAAPPPGPGPSDSPEAAVEKVEVEL...unknowninhibitor
b(0,+)-type amino acid transporter 1MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFV...unknown
Amino acid transporter heavy chain SLC3A1MAEDKSKRDSIEMSMKGCQTNNGFVHNEDILEQTPDPGSSTDNLKHSTRG...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 6992103, 67678
ChEMBL CHEMBL590540
ChEBI CHEBI:16283, CHEBI:35491
CCDC/CSD CYSTCL04, CYSTCL03, YUZTAQ, CYSTBR02, CYSTCL02, XOLKAL, XOLJUE, CYSTCL01, CYSTBR01